EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia

Sali Alharbi, Azzam Alkhalifah

Skin Appendage Disorders · 19.01.2026 · 12 (4) · 283-295

DOI: 10.1159/000550540 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Skin Appendage Disorders, online erschienen am 19.01.2026. Verfasst von Sali Alharbi und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Qassim University, Buraydah, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) demonstrate remarkable efficacy for weight management, emerging pharmacovigilance data suggest an increased hair loss risk, particularly with newer agents. This study investigated the prevalence, risk factors, and clinical impact of hair shedding in GLP-1 RA users in Saudi Arabia.

Methods

A cross-sectional survey was conducted between September 2024 and January 2025 of current and former GLP-1 RA users. Participants with preexisting hair loss were excluded from the study. Hair shedding prevalence, associated factors, and the impact on treatment discontinuation were assessed using validated questionnaires. Multivariate logistic regression was used to identify independent predictors.

Results

Among 152 eligible participants (87.5% female, median body mass index 32.1 kg/m2), 70.4% (n = 107) reported hair shedding after GLP-1 RA initiation, which was markedly higher than the 3–7% reported in clinical trials. Tirzepatide users had the highest prevalence (76.7%), followed by semaglutide (64%) and liraglutide (54.5%). Hair shedding was significantly associated with female sex (92.5% vs. 75.6% in males, p = 0.009), greater magnitude of weight loss (82.7% prevalence with ≥15% weight loss vs. 40% with

Schlagwörter

Stichwörter der Autor:innen

Drug safetyGLP-1 receptor agonistsHair lossTelogen effluviumWeight loss

Autor:innen und Institutionen

  • College of Medicine, Qassim University, Buraydah, Saudi Arabia.
  • Department of Dermatology, College of Medicine, Qassim University, Unaizah, Saudi Arabia.

Zitieren

APA

Alharbi, S., & Alkhalifah, A. (2026). Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia. Skin Appendage Disorders, 12(4), 283-295. https://doi.org/10.1159/000550540

Vancouver

Alharbi S, Alkhalifah A. Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia. Skin Appendage Disorders. 2026;12(4):283-295. doi:10.1159/000550540

BibTeX
@article{Alharbi2026,
  author = {Alharbi, Sali and Alkhalifah, Azzam},
  title = {Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia},
  journal = {Skin Appendage Disorders},
  year = {2026},
  volume = {12},
  number = {4},
  pages = {283--295},
  doi = {10.1159/000550540}
}
Kostenlos starten →